logo
People suffering from heartburn to be offered life-saving cancer check in pharmacies

People suffering from heartburn to be offered life-saving cancer check in pharmacies

Daily Mail​09-07-2025
Heartburn sufferers will be offered a 'sponge on a string' test on the high-street for the first time in a bid to catch the earliest potential signs of a deadly cancer.
Patients with persistent heartburn or acid reflux will be eligible to take the test—where they swallow a special pill containing a sponge—in a bid to spot a condition which dramatically increases the risk of developing oesophageal cancer.
Oesophageal cancer—which forms in the food pipe—is often caught too late with four out of five patients dying within a year.
Now, a new NHS England initiative aims to catch patients with a condition Barrett's oesophagus in a bid to prevent cancer cases from occurring.
The pilot—which starts next year—will see 1,500 patients in London and the East Midlands offered a 'heartburn health check' at their high street pharmacy.
Pharmacists will specifically look for patients who regularly purchase over-the-counter drugs to ease their heartburn but who may not have seen their GP about it.
They will then be offered the sponge on a string test. This sees a patient swallow a small capsule, containing a tiny sponge, attached to a thin string.
The capsule then dissolves in the stomach and the sponge within expands to the size of 1p coin.
After a few minutes the sponge is pulled up via the string.
During this process it collects cells from the food pipe which can then be sent to a lab and tested for Barrett's oesophagus.
Barrett's oesophagus occurs when stomach acid rising up into the food pipe—which causes heartburn—damages the tissue inside.
In some cases, the damaged tissue may have abnormal changes, which may one day become cancer.
Studies have found people with Barrett's oesophagus have an 11-times greater risk of developing oesophageal cancer.
While the sponge on a string test has been offered in hospitals and other clinical settings for years, this is the first time it will be offered in a high-street setting.
The NHS says if the two-year pilot is successful the initiative could be rolled out to more parts of the country.
Professor Peter Johnson, NHS national cancer director, said: 'For the majority of people with persistent reflux, these quick and easy heartburn health checks will provide peace of mind that you aren't at increased risk of cancer.'
'For those who do find out they have Barrett's oesophagus, regular follow-up checks will be put in place so any further cell changes can be spotted early.'
If worrying sings are detected patients can have treatments to have the cells removed.
Almost 10,000 patients are diagnosed with oesophageal cancer in the UK each year, with four in five diagnosed at a later, harder to treat, stage.
The cancer kills almost 8,000 Britons each year, the vast majority with just 12 months of diagnosis.
Eddie, aged 77 from Suffolk, says the sponge on a string test may have saved his life after suffering for years with persistent heartburn.
'To think that something as simple as swallowing a capsule could uncover a hidden risk is truly remarkable,' he said.
'Knowing I have Barrett's oesophagus meant I was prioritised, my condition was monitored, and as a result my dysplasia (cell changes) was caught early.
'This test gave me peace of mind and access to early treatment and could mean the difference between life and death for so many others.'
The NHS has partnered with Boots and diagnostics company Cyted Health for the pilot, alongside Heartburn Cancer UK.
Public health minister Ashley Dalton said: 'Last week, as part of our 10-year health plan, we promised a neighbourhood health service–convenient care nearer to where people live.
'Today's announcement is a fantastic example of the life-saving potential of healthcare on your high street.'
Before the invention of the sponge on a string test patients suspected of having Barrett's oesophagus had to undergo an endoscopy—where flexible camera is inserted into the mouth and down the food pipe—a far more invasive procedure.
In addition to heartburn and indigestion a sore throat—especially when swallowing—is another common sign of the disease.
Patients are urged to contact their doctor if they have heartburn for three weeks or more or any other symptoms like problems swallowing or losing weight unexpectedly.
While most likely not cancer, an early diagnosis—when the disease is typically easier to treat—can vastly improve outcomes for patients.
Data suggest that oesophageal is on the rise in Britain with cases having increased 3 per cent since the 90s overall and 10 per cent in men specifically.
Earlier this year figures showed Britain has one of the highest rates of the disease in Europe.
The cancer kills 22 patients per day in the UK, one of the highest rates in Europe.
Data show the UK has 14.2 new cases of oesophageal cancer per 100,000 people per year.
This is quadruple Italy's 3.5 cases per 100,000 people per year, triple Spain's 4.4 and double or almost double France's and Germany rate of 7 and 7.7.
Only the Netherlands narrowly beats Britain in Western Europe, sneaking ahead at 14.9 cases.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Women with advanced cancer get fresh hope as new treatment approved on NHS
Women with advanced cancer get fresh hope as new treatment approved on NHS

The Independent

time7 minutes ago

  • The Independent

Women with advanced cancer get fresh hope as new treatment approved on NHS

Thousands of women battling an advanced form of womb cancer have been offered renewed hope after a new treatment was approved for widespread use on the NHS. Currently, just 15 per cent of women diagnosed with advanced (stage four) endometrial cancer – which typically originates in the lining of the womb – survive for five years. The treatment, known as pembrolizumab, has been shown to slow cancer growth and significantly improve survival odds, health officials said. The National Institute for Health and Care Excellence (Nice) estimates that approximately 2,100 women across England will benefit from the therapy each year. Nice hailed its approval as a "major step forward" in the treatment of the cancer. The treatment, also known as Keytruda and made by Merck Sharp and Dohme, is an immunotherapy drug and is delivered in a drip alongside chemotherapy drugs carboplatin and paclitaxel. It can be given for up to two years. Nice said that clinical trials show the combination of treatments reduced the risk of death by 26 per cent compared to chemotherapy alone. The treatments can also slow down cancer progression, it added. 'For people with advanced endometrial cancer, this innovative combination offers a powerful new treatment option,' said Helen Knight, director of medicines evaluation at Nice. 'It marks a major step forward, and we're pleased to recommend it as part of our commitment to getting the best care to people, fast, while ensuring value for the taxpayer.' Around 9,700 women are diagnosed with endometrial cancer each year, Nice said, making it the most common gynaecological cancer in the UK. Helen Hyndman, lead nurse at the charity Eve Appeal's information service Ask Eve, said: 'Primary advanced or recurrent womb (endometrial) cancer has a huge impact on the quality of life for those diagnosed. 'It is great news that this new treatment has been approved. 'It will offer hope, a better quality of life and improve outcomes for those affected.' Professor Peter Johnson, NHS England's national clinical director for cancer, said: 'Getting this treatment to many more NHS patients as quickly as possible will help thousands of women live longer, allowing them to spend more time with loved ones and give them a better quality of life. 'Thanks to the NHS's Cancer Drugs Fund, it is now being fast-tracked into routine use, with treatment available to more patients from today.'

BBC presenter opens up health scare that saw him rushed to hospital after covering Wimbledon as he admits the ordeal was a 'wake-up call'
BBC presenter opens up health scare that saw him rushed to hospital after covering Wimbledon as he admits the ordeal was a 'wake-up call'

Daily Mail​

time7 minutes ago

  • Daily Mail​

BBC presenter opens up health scare that saw him rushed to hospital after covering Wimbledon as he admits the ordeal was a 'wake-up call'

BBC presenter Qasa Alom has reflected on a recent health scare after working at Wimbledon, which saw him rushed to hospital, revealing it was a 'wake-up call'. Alom was the host of the Today at Wimbledon show for Britain's largest public broadcaster, a role he assumed in 2023. However, the Birmingham-born anchor pushed his body to its limit in order to work at Tennis' most prestigious championships, despite knowledge of an illness that he has yet to disclose. That decision ended with Alom in an ambulance and on his way to hospital, and now the presenter has taken to Instagram to open up about the ordeal. 'I can't say the last few weeks have been easy,' Alom wrote. 'Ever since the middle of Wimbledon, I've been battling my body with a health issue. 'I put off getting proper medical care because I just did not want to miss The Championships (error). Eventually, it became too much & escalated. The post consisted of numerous pictures of Alom that range from being picked up in an ambulance to receiving treatment. And while the presenter can be seen smiling in the majority of the photographs, he has admitted that the ordeal knocked him 'for six'. 'A real wake-up call to all those health-conscious young seemingly fit people out there seeing this,' he continued. 'No matter how good your VO2 max might be; or what your resting heart rate is….no matter how many chia seeds you eat or interval fasts you can do….things can happen inside of our bodies that you can't control and it will completely knock you for six. 'Respect your body and its limitations. We only have one. Grateful to my family for helping me through a difficult period & now the road to recovery.' When Clare Balding left the BBC's Today at Wimbledon show to lead the championships' coverage, following Sue Barker's departure, there was a vacancy to be filled. Alom, a huge tennis fan (and self-proclaimed tennis 'geek'), was the man to take the mantle from Balding. He previously presented a Radio 4 programme on one of the sport's most iconic stars, Arthur Ashe, and also takes an interest in cricket, rugby and athletics. In 2022, Alom was part of the team on the BBC's coverage of the Commonwealth Games as well as the London Marathon - and has also been at the helm of shows on the BBC's Asian Network and 5 Live. Elsewhere, the filmmaker has his own YouTube channel, QasaVision, which explores issues stemming from the climate crisis, and he is passionate about protecting the environment. However, the star on the screen has not posted a video on the channel for over two years.

The bestselling anti-ageing cream Boots can't keep in stock 'works in just SEVEN days' - now 50% off: 'No more crepey neck'
The bestselling anti-ageing cream Boots can't keep in stock 'works in just SEVEN days' - now 50% off: 'No more crepey neck'

Daily Mail​

time24 minutes ago

  • Daily Mail​

The bestselling anti-ageing cream Boots can't keep in stock 'works in just SEVEN days' - now 50% off: 'No more crepey neck'

Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more The bestselling neck cream at Boots, the PRAI Ageless Throat & Décolletage Crème, is now 50 per cent off for MailOnline readers in an exclusive deal. Clinically proven to work from as little as seven days, the anti-ageing neck and chest cream is being snapped up by shoppers looking to fade fine lines from their cleavage to their chin. And the award-winning £45.99 pot is proving to be so effective that it's sold over 10 million jars globally. And counting. PRAI Beauty Ageless Throat and Decolletage Creme 118ml SUPERSIZE The number one neck cream at Boots, PRAI Ageless Throat & Decolletage Crème 118ml was £45.99 but is now £22.99 thanks to our exclusive code MAIL50. Running until October 31, it's a great time to invest in the supersize pot. Said to be the secret to a firmer, smoother, younger-looking neck and décolletage, the brand's number one bestseller contains a powerhouse of hyaluronic acids, sepilift, along with shea butter, squalene, mulberry and grapeseed extract, as well as vitamins A, E and F for clinically-proven results in just seven days. £22.99 (save £22.99) Shop Before and after: PRAI Beauty Ageless Throat and Decolletage Creme gets to work fast to improve the look of fine lines on the chest and neck and improve elasticity Available to shop at Boots, the PRAI Beauty Ageless Throat & Décolletage Creme has helped scores of shoppers to 'hold back signs of ageing' with many frequent users reporting how their skin 'looks firmer and less saggy and lined'. And better still? In a rare and exclusive deal, MailOnline readers can score the PRAI Ageless Throat & Decolletage Crème 118ml (the larger size) for just £22.99 with the code MAIL50 - that's half price. Said to be the secret to a firmer, smoother, younger-looking neck and décolletage, the number one brand bestseller promises to help the appearance of crepey neck, jowls and sagging in just seven days. And according to shoppers, the results are 'marvelous'. 'I've been using this for a little over a week and have seen a difference already' raved one impressed user. 'My skin feels great and if these early results are anything to go by, this pot of magic is here to stay!'. As the skin on our neck and decollatage is thinner than many parts on our body, these areas tend to age faster than the rest due to loss of elasticity. This can cause sagging, thinning skin, with an increase in fine lines. This is where the PRAI Beauty Ageless Throat & Décolletage Creme comes in. Formulated with a powerhouse of hyaluronic acids, sepilift, along with shea butter, squalene, mulberry and grapeseed extract, as well as vitamins A, E and F, you can expect to see visible, clinically-proven results in just seven days. With consistent use, shoppers have revealed even more impressive results: 'This is one product that actually does what it says! I have been using for over 6 months now and would bathe in this if I could. It has a lovely lightweight texture, it goes on easily and the effects were noticeable within a few days. No crepey neck and décolleté for me.' Those feeling insecure or even noticing the first signs of ageing on their neck, are making a beeline for this bestseller. And with over 700 perfect five-star reviews on it could be well worth the investment. PRAI recommend applying a pea-sized amount daily in smooth upward strokes from cleavage to chin. For best results, use twice a day. Shoppers have even taken to the review section to compare it to other more expensive brands, with one writing: 'Nothing compares. The best neck cream on the market, band I should know as I've tried a lot!'. The supersize PRAI Beauty Ageless Throat and Decolletage Creme 118ml can be yours for half price thanks to our MailOnline exclusive code. Just use the code MAIL50 to redeem the generous pot for £22.99. This promotion ends October 31.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store